UCSF Health Hits Record Heart Transplant Volume

UCSF Health completed more than 80 heart transplants in 2026, its highest transplant volume on record, with Paragonix supporting donor heart recovery since January.

Updated on Nov. 19, 2026 in Healthcare

UCSF Health Hits Record Heart Transplant Volume

Live Poll

Should the U.S. do more to increase the supply of donor organs?

UCSF Health completed more than 80 heart transplants in 2026, its highest transplant volume on record. Paragonix Transplant Services has supported UCSF's donor heart recovery and transplant workflow since a partnership began in January 2026.

Why it matters

Growing a transplant program requires more capacity than one team can provide alone, and demand for donor organs exceeds supply nationally. The national transplant waiting list is growing longer, making added evaluation and recovery capacity at transplant centers increasingly important.

UCSF Health completed more than 80 heart transplants in 2026, a record for the institution. Paragonix Transplant Services supports the program around the clock from regional hubs, though the company did not disclose how many cases it has handled.

The players

UCSF Health

UCSF Health is the clinical enterprise of the University of California, San Francisco, operating major academic medical centers and transplant programs in the San Francisco Bay Area.

Paragonix Technologies

Paragonix Technologies is a medical device company based in Waltham, Massachusetts, known for organ preservation and transport systems, and is a Getinge company.

The details

Paragonix provides organ offer coordination, organ evaluation, surgical recovery, logistics and transport for UCSF Health. Its team includes ACIN-certified recovery surgeons, surgical assistants and certified preservationists who work alongside UCSF's transplant teams, with customized support for each case from the first call through delivery.

Timeline

  1. January 2026: Paragonix and UCSF Health's partnership began.

  2. 2026: UCSF completed more than 80 heart transplants, a record.

  3. November 19, 2026: Paragonix announced the ongoing partnership.

Supply Gap

UCSF's record year reflects a center adding capacity against a national transplant waiting list that the source describes as growing longer, with donor demand continuing to exceed available organs. Expanded evaluation and recovery support is one response to that imbalance.

Patients awaiting a heart transplant at UCSF Health may benefit from expanded evaluation and recovery capacity as the center handles a larger caseload. Support is coordinated around the clock, which can affect how quickly donor organs are assessed and delivered.

The takeaway

Expanding a transplant program depends on adding evaluation and recovery capacity, not just surgical teams. Readers interested in organ donation can check their local donor registry to help narrow the gap between donor demand and supply.

Further reading

Explore more healthcare coverage in San Francisco to see how local transplant programs fit into the regional medical landscape.

More information

Learn about the support available through Paragonix Transplant Services clinical services information.

Source note: This article includes information reported by The Manila times.

Live Poll

Should the U.S. do more to increase the supply of donor organs?